title: [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
abstract: About 2 or 3 weeks after transplantation, even ABO-Incompatible bone marrow shows a successful graft. Haemopoiesis is not always free of problems. Suppression of erythropoiesis is caused by persistently incompatible agglutinins. Patient's well-being is limited by longer periods of low levels of haemoglobin concentration. Long-lasting need for transfusions is related to the well-known risk of infections. A procedure to eliminate the residual titers of alloantibodies should be discussed in time with the staff of the transfusion department.
authors.affiliation: Blutspende- und Transfusionsdienst, Universitätsklinikum Essen.
authors.forename: K B
authors.initials: KB
authors.lastname: Henneberg-Quester
authors.forename: W
authors.initials: W
authors.lastname: Luboldt
authors.forename: U W
authors.initials: UW
authors.lastname: Schaefer
authors.forename: D W
authors.initials: DW
authors.lastname: Beelen
authors.forename: K
authors.initials: K
authors.lastname: Quabeck
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D001787:Blood Group Incompatibility / Q000097:blood / Q000517:prevention & control*; D001788:Blood Grouping and Crossmatching / Q000379:methods*; D001803:Blood Transfusion / Q000379:methods*; D016026:Bone Marrow Transplantation / Q000379:methods*; D017707:Erythrocyte Transfusion; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007518:Isoantibodies / Q000378:metabolism*; D010951:Plasma Exchange / Q000379:methods
chemical_list: D000017:ABO Blood-Group System; D007518:Isoantibodies
vernacular_title: Erythrozytensubstitution und Isoagglutinintiter nach ABO-inkompatibler Knochenmark-transplantation.